APON(SZ:300753) Sou Hu Cai Jing·2025-08-13 15:20Core Viewpoint - The recent stock trading activities of Aipeng Medical's executive, Li Qing, indicate a reduction in shareholding, which may reflect the company's current market sentiment and executive confidence in future performance [1][3]. Company Overview - Aipeng Medical's main business scope includes the production and sale of various medical devices and healthcare products, with a focus on pain management and respiratory products [2]. - As of December 31, 2024, the company's revenue from pain management products was 248 million yuan, accounting for 61.52% of total revenue, while revenue from nasal and upper airway products was 123 million yuan, making up 30.55% [2]. Executive Trading Activities - On August 12, 2025, Li Qing sold 14,900 shares at an average price of 35.00 yuan, resulting in a total transaction value of 521,500 yuan, reducing his holdings to 357,500 shares [1][3]. - Li Qing's previous transactions included selling 89,300 shares on August 8, 2025, at an average price of 37.94 yuan, totaling 3.39 million yuan [3]. - The total market capitalization of Aipeng Medical is reported to be 4.505 billion yuan [3].